Retinal Diseases: Clinical Presentation and Novel Treatments

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: 31 August 2024 | Viewed by 1091

Special Issue Editors


E-Mail Website
Guest Editor
Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI 48105, USA
Interests: ophthalmology; artificial intelligence; space medicine; optical coherence tomography; machine learning

Special Issue Information

Dear Colleagues,

The retina plays a critical role in vision and quality of life. Preserving the retina in aging and disease is of the utmost importance. Within the past decade, therapies and imaging techniques for retinal diseases have emerged. Advances in imaging, including various optical coherence tomography (OCT) techniques, OCT angiography, multi confocal scanning laser ophthalmoscopy (MCSLO), and adaptive optics, have revolutionized how we can detect and understand retinal disease presentation. Various therapies that have revolutionized retinal disease management have also been introduced, such as multiple anti-VEGF intravitreal injection therapies for neovascular age-related macular degeneration. Research has also focused on various treatments, including gene therapy, complement component targeting, episcleral brachytherapy, subthreshold micropulse laser, and port delivery systems.

We are pleased to invite you to submit your work for a new Special Issue entitled “Retinal Diseases: Clinical Presentation and Novel Treatments”. We welcome the submission of original research articles or reviews that discuss the recent advances in understanding the clinical presentation of retinal disease and/or the novel treatments that have emerged for these diseases.

Dr. Joshua Ong
Dr. Jay Chhablani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • retina
  • clinical presentation
  • age-related macular degeneration
  • choroid
  • chorioretinal disease
  • optical coherence tomography
  • novel therapies

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 1105 KiB  
Review
Microbial Dynamics in Ophthalmic Health: Exploring the Interplay between Human Microbiota and Glaucoma Pathogenesis
by Joicye Hernández-Zulueta, Andres J. Bolaños-Chang, Francisco J. Santa Cruz-Pavlovich, América D. Valero Rodríguez, Alejandro Lizárraga Madrigal, Ximena I. Del Rio-Murillo, José Navarro-Partida and Alejandro Gonzalez-De la Rosa
Medicina 2024, 60(4), 592; https://doi.org/10.3390/medicina60040592 - 3 Apr 2024
Viewed by 824
Abstract
The human microbiome has a crucial role in the homeostasis and health of the host. These microorganisms along with their genes are involved in various processes, among these are neurological signaling, the maturation of the immune system, and the inhibition of opportunistic pathogens. [...] Read more.
The human microbiome has a crucial role in the homeostasis and health of the host. These microorganisms along with their genes are involved in various processes, among these are neurological signaling, the maturation of the immune system, and the inhibition of opportunistic pathogens. In this sense, it has been shown that a healthy ocular microbiota acts as a barrier against the entry of pathogens, contributing to the prevention of infections. In recent years, a relationship has been suggested between microbiota dysbiosis and the development of neurodegenerative diseases. In patients with glaucoma, it has been observed that the microbiota of the ocular surface, intraocular cavity, oral cavity, stomach, and gut differ from those observed in healthy patients, which may suggest a role in pathology development, although the evidence remains limited. The mechanisms involved in the relationship of the human microbiome and this neurodegenerative disease remain largely unknown. For this reason, the present review aims to show a broad overview of the influence of the structure and composition of the human oral and gut microbiota and relate its dysbiosis to neurodegenerative diseases, especially glaucoma. Full article
(This article belongs to the Special Issue Retinal Diseases: Clinical Presentation and Novel Treatments)
Show Figures

Figure 1

Back to TopTop